Safety and Efficacy of Allogeneic Hematopoetic Stem Cell Transplant (HSCT) after Treatment with Programmed Cell Death 1 (PD-1) Inhibitors

被引：0

作者：

Merryman, Reid W. ^{[1
]}

Kim, Haesook T. ^{[2
]}

Zinzani, Pier Luigi ^{[3
]}

Carlo-Stella, Carmelo ^{[4
]}

Ansell, Stephen M. ^{[5
]}

Halwani, Ahmad S. ^{[6
]}

Perales, Miguel-Angel ^{[7
]}

Ho, Vincent T. ^{[8
]}

Antin, Joseph H. ^{[8
]}

Ritz, Jerome ^{[9
]}

Soiffer, Robert J. ^{[8
]}

Armand, Philippe ^{[10
]}

机构：

[1] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA

[2] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA

[3] Univ Bologna, Inst Hematol L&A Seragnoli, Bologna, Italy

[4] Humanitas Clin & Res Ctr, Milan, Italy

[5] Mayo Clin, Rochester, MN USA

[6] Huntsman Canc Inst, Salt Lake City, UT USA

[7] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA

[8] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA

[9] Dana Farber Canc Inst, Div Hematol Malignancies, Boston, MA 02115 USA

[10] Dana Farber Canc Inst, Boston, MA 02115 USA

来源：

BLOOD | 2015年 / 126卷 / 23期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[41] The Role of Programmed Cell Death 1/Programmed Death Ligand 1 (PD-1/PD-L1) Axis in Sepsis-Induced Apoptosis [J].

Coman, Oana ;

Grigorescu, Bianca-Liana ;

Hutanu, Adina ;

Bacarea, Anca ;

Vasiesiu, Anca Meda ;

Fodor, Raluca Stefania ;

Stoica, Florin ;

Azamfirei, Leonard .

MEDICINA-LITHUANIA, 2024, 60 (07)

[42] Neurological adverse effects due to programmed death 1 (PD-1) inhibitors [J].

Siyu Shi ;

Joseph Abi Jaoube ;

Ruhi Kanwar ;

Michael C. Jin ;

Alvaro Amorin ;

Vamsi Varanasi ;

Ella Eisinger ;

Reena Thomas ;

Justin M. Moore .

Journal of Neuro-Oncology, 2020, 148 :291-297

[43] Correction to: Programmed death 1 ligand (PD-L1) in solid cancers after allogeneic hematopoietic stem cell transplantation: a retrospective analysis by the Nagasaki Transplant Group [J].

Sachie Kasai ;

Hidehiro Itonaga ;

Daisuke Niino ;

Hiroaki Miyoshi ;

Takeharu Kato ;

Daisuke Imanishi ;

Machiko Fujioka ;

Takafumi Furumoto ;

Shinya Sato ;

Yasushi Sawayama ;

Jun Taguchi ;

Yoshitaka Imaizumi ;

Tomoko Hata ;

Shinichiro Yoshida ;

Yukiyoshi Moriuchi ;

Koichi Ohshima ;

Yasushi Miyazaki .

International Journal of Hematology, 2020, 112 :906-906

[44] Neurological adverse effects due to programmed death 1 (PD-1) inhibitors [J].

Shi, Siyu ;

Jaoube, Joseph Abi ;

Kanwar, Ruhi ;

Jin, Michael C. ;

Amorin, Alvaro ;

Varanasi, Vamsi ;

Eisinger, Ella ;

Thomas, Reena ;

Moore, Justin M. .

JOURNAL OF NEURO-ONCOLOGY, 2020, 148 (02) :291-297

[45] A new frontier for targeted therapy in NSCLC: clinical efficacy of pembrolizumab in the inhibition of programmed cell death 1 (PD-1) [J].

Addeo, Raffaele .

EXPERT REVIEW OF ANTICANCER THERAPY, 2017, 17 (03) :199-201

[46] SYSTEMATIC REVIEW OF EFFICACY OF PROGRAMMED DEATH (PD)-1 AND PD-LIGAND-1 INHIBITORS IN THE TREATMENT OF NON-SMALL CELL LUNG CANCER [J].

Lingohr-Smith, M. ;

Deitelzweig, C. ;

Lin, G. ;

Lin, J. .

VALUE IN HEALTH, 2020, 23 :S426-S426

[47] Efficacy and safety profiles of programmed cell death-1/programmed cell death ligand-1 inhibitors in the treatment of triple-negative breast cancer: A comprehensive systematic review [J].

Lazarus, Gilbert ;

Audrey, Jessica ;

Iskandar, Anthony William Brian .

ONCOLOGY REVIEWS, 2019, 13 (02) :161-169

[48] Programmed cell death ligand 1 (PD-L1) inhibitors versus programmed cell death 1 (PD-1) inhibitors for the first-line therapy of extensive-stage small cell lung cancer: A propensity score-matched study [J].

Tian, Yaru ;

Lu, Shuangqing ;

Sun, Yulan ;

Tang, Xiaoyong ;

Sun, Zhuoran ;

Zhao, Ke ;

Du, Guochang ;

Li, Wanjing ;

Zhu, Hui .

JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

[49] Clinical and pathological significance of programmed cell death 1 (PD-1)/programmed cell death ligand 1 (PD-L1) expression in high grade serous ovarian cancer [J].

Ba, Yilmaz ;

Koc, Nermin ;

Helvac, Kaan ;

Kocak, Cem ;

Akdeniz, Rasit ;

Sahin, Havva Hande Keser .

TRANSLATIONAL ONCOLOGY, 2021, 14 (02)

[50] Safety and efficacy of the BCR inhibitors after allogeneic stem cell transplantation for CLL [J].

Yanez, Lucrecia ;

Ferra, Christelle ;

Alcoceba, Miguel ;

Gonzalez, Marcos ;

Andreu, Rafael ;

Espigado, Ildefonso ;

Loscertales, Javier ;

Garcia Marco, Jose Antonio ;

Jose Terol, Maria ;

Solano, Carlos ;

Bosch, Francesc .

BONE MARROW TRANSPLANTATION, 2019, 54 :200-201

← 1 2 3 4 5 →